Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
Therapeutic Advances in Gastroenterology
|
February 24, 2022
A review of the therapeutic management of Crohn's disease
Aditi Kumar, Alexander Cole, Jonathan Segal, et al.
Frontline Gastroenterology
|
October 26, 2020
Training in endotherapy for acute upper gastrointestinal bleeding: a UK-wide gastroenterology trainee survey
Jonathan Segal, Keith Siau, Cynthia Kanagasundaram, et al.
BMC Proceedings
|
February 26, 2014
Better primer design for metagenomics applications by increasing taxonomic distinguishability
Melita Jaric, Jonathan Segal, Eugenia Silva-Herzog, et al.
Frontline Gastroenterology
|
December 30, 2021
What next for gastroenterology and hepatology trainee networks? Lessons from our surgical colleagues
Jonathan Segal, Monika Widlak, Richard J M Ingram, et al.
The Lancet. Gastroenterology & Hepatology
|
February 15, 2025
Vedolizumab for prevention of recurrence of Crohn's disease
Andrew Nguyen, Christopher F D Li Wai Suen, Ashish Srinivasan, et al.
The Lancet. Gastroenterology & Hepatology
|
September 22, 2024
Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis
Beatriz Gros, Jonathan Blackwell, Jonathan Segal, et al.
Journal of Clinical Microbiology
|
November 24, 2006
First reported infections caused by three newly described genera in the family Xanthomonadaceae
P Rocco LaSala, Jonathan Segal, Faye S Han, et al.
Frontline Gastroenterology
|
December 17, 2021
Are we addressing the top 10 research priorities in IBD?
Jeroen Geldof, Jean-Frédéric LeBlanc, Laura Lucaciu, et al.
The Lancet. Gastroenterology & Hepatology
|
September 22, 2024
Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis
Shahida Din, Jonathan Segal, Jonathan Blackwell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 21, 2024
Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study
Ashish Srinivasan, Daniel van Langenberg, Peter De Cruz, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
Therapeutic Advances in Gastroenterology
|
February 24, 2022
A review of the therapeutic management of Crohn's disease
Aditi Kumar, Alexander Cole, Jonathan Segal, et al.
Frontline Gastroenterology
|
October 26, 2020
Training in endotherapy for acute upper gastrointestinal bleeding: a UK-wide gastroenterology trainee survey
Jonathan Segal, Keith Siau, Cynthia Kanagasundaram, et al.
BMC Proceedings
|
February 26, 2014
Better primer design for metagenomics applications by increasing taxonomic distinguishability
Melita Jaric, Jonathan Segal, Eugenia Silva-Herzog, et al.
Frontline Gastroenterology
|
December 30, 2021
What next for gastroenterology and hepatology trainee networks? Lessons from our surgical colleagues
Jonathan Segal, Monika Widlak, Richard J M Ingram, et al.
The Lancet. Gastroenterology & Hepatology
|
February 15, 2025
Vedolizumab for prevention of recurrence of Crohn's disease
Andrew Nguyen, Christopher F D Li Wai Suen, Ashish Srinivasan, et al.
The Lancet. Gastroenterology & Hepatology
|
September 22, 2024
Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis
Beatriz Gros, Jonathan Blackwell, Jonathan Segal, et al.
Journal of Clinical Microbiology
|
November 24, 2006
First reported infections caused by three newly described genera in the family Xanthomonadaceae
P Rocco LaSala, Jonathan Segal, Faye S Han, et al.
Frontline Gastroenterology
|
December 17, 2021
Are we addressing the top 10 research priorities in IBD?
Jeroen Geldof, Jean-Frédéric LeBlanc, Laura Lucaciu, et al.
The Lancet. Gastroenterology & Hepatology
|
September 22, 2024
Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis
Shahida Din, Jonathan Segal, Jonathan Blackwell, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
August 21, 2024
Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study
Ashish Srinivasan, Daniel van Langenberg, Peter De Cruz, et al.
Page
of 5